Are you sure?

Egis shareholders approve bigger dividend

Shareholders of Hungarian drugmaker Egis, majority-owned by France's Sevier, approved a proposal to pay a HUF 240-per-share dividend on profit from the business year ended September 30 at an annual general meeting on Wednesday. The dividend is double the HUF 120-per-share dividend that Egis has paid for years. CFO Csaba Poroszlai said the dividend was 10% of consolidated net profit. Shareholders approved Egis's Hungarian Accounting Standards P+L statement showing after-tax profit of HUF 20.4 billion on revenue of HUF 131.2 billion.